HmmWonder if all this cleaning up of loose ends is just setting the company up for a buyout or a sale of Delta or Farmako. If it happens we could end up holding shares in one of the big companies. Wouldn't help those that got in at the high double digits, but could mean a lot to those that got in sub .20. If I recall that last MD&A mentioned that a lot of consulting was done by companies owned Management or Directors. The press release suggests they are at arms length. That's we need the consultants names.
November MD&A
The Company has identified the directors and senior officers as key management personnel. The following table lists the compensation costs paid directly or to companies controlled by key management personnel for the period ended September 30, 2018 and the year ended December 31, 2017: Nine months ended September 30, 2018 Fees Share-based compensation Christopher Hornung $ - $ - Cherry Consulting Ltd 18,600 - Elben Capital Inc. 98,000 617,898 FourOneSix Inc. 125,000 308,949 Clairewood Partners / David Parry 30,250 617,898 Jerry Habuda - - Shawn Moniz - - Joseph Perino - - $ 271,850 $ 1,544,745 Year ended December 31, 2017 Fees Share-based compensation Christopher Hornung $ 7,500 $ - Cherry Consulting Ltd 34,704 27,741 Elben Capital Inc / Derek Ivany 134,190 36,862 FourOneSix Inc. 80,000 9,881 Clairewood Partners / David Parry 31,000 452,988 Jason Springett - - Jerry Habuda 7,500 - Joseph Perino 7,500 - Shawn Moniz 0 9,881 $ 302,394 $ 537,353